Alan Baptist, MD
Allergy & Immunology · Ann Arbor, MINPI 1043257751
Payments from drug & device makers
Across 857 payments — averaging $2868.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1.2M
- Takeda Pharmaceuticals U.S.A., Inc.$523K
- Biocryst Pharmaceuticals, Inc.$130K
- Regeneron$116K
- Incyte Corporation$92K
- Shire North American Group Inc$91K
- plus $325K from 20 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 51 | $1,181,533 |
| Takeda Pharmaceuticals U.S.A., Inc. | 503 | $523,428 |
| Biocryst Pharmaceuticals, Inc. | 38 | $129,796 |
| Regeneron | 25 | $115,683 |
| Incyte Corporation | 70 | $91,501 |
| Shire North American Group Inc | 10 | $90,629 |
| Astrazeneca UK Limited | 7 | $85,380 |
| GSK | 40 | $76,462 |
| Teva Pharmaceuticals USA, Inc. | 30 | $49,939 |
| Amgen | 5 | $31,659 |
| CSL Behring | 29 | $27,305 |
| Novartis | 9 | $21,408 |
| Genentech, Inc. | 4 | $13,993 |
| Sanofi US Services Inc. | 4 | $4,538 |
| Biocryst US Sales Co., LLC | 6 | $3,135 |
| Ionis Pharmaceuticals, Inc. | 1 | $2,840 |
| Regeneron Healthcare Solutions, Inc. | 6 | $2,461 |
| Acerta Pharma LLC | 1 | $1,774 |
| Alk-abello, Inc | 6 | $1,773 |
| Cycle Pharmaceuticals Inc | 1 | $1,034 |
| Genentech USA, Inc. | 1 | $880 |
| Sanofi | 6 | $484 |
| Aquestive Therapeutics, Inc. | 1 | $119 |
| Optinose US, Inc. | 1 | $90 |
| Blueprint Medicines Corporation | 1 | $46 |
| Pharming Healthcare, Inc. | 1 | $17 |
How this compares
$2,457,907 in reported general payments places this provider in the 95th percentile of 119 allergy & immunology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Ann Arbor
- Georgiana SandersAnn Arbor$607K
- Kelly O'SheaAnn Arbor$156K
- James BakerAnn Arbor$91K
- Ian SlackAnn Arbor$62K
- Malika GuptaAnn Arbor$5K
- Jeffrey LefleinYpsilanti$7.9M
- Cem AkinNorthville$3M
- Suresh AnneFlint$1.1M
- Steven StrykCanton$949K
- Hassan NasirWest Branch$736K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.